CTRI/2024/05/067325尚未招募Unknown
Evaluation of safety and effectiveness of biozen syrup in the management of hyperlipidemia- An open-label study. - NI
Aathithya herbals0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male or female with age of 20-60 years.
- •2. BMI between 25 to 40 kg/m2.
- •3. Subjects with elevated lipid profile parameters.
- •(i) Total Cholesterol more than 200mg/dl (or)
- •(ii) Triglycerides more than 150mg/dl (or)
- •(iii) LDL more than 130mg/dl
- •4. Willing to give written informed consent.
排除标准
- •1. Subjects with abnormal hematologic function (Hemoglobin 8gm/dl, WBC count
- •3000/mm3, platelet count 100,000/mm3).
- •2. Any concomitant serious disorders of the liver ,kidneys , heart, lungs and other organs
- •3. Evidence of psychiatric disorder, antagonistic personality, poor motivation, emotional or
- •intellectual problems likely to limit the validity of consent to participate in the study or
- •limit the ability to comply with protocol requirements.
- •4. Abnormally elevated liver enzymes (ALT and/or AST more than 2 times ULN).
- •5. Elevated creatinine phosphokinase (CPK) (more than 3 times ULN).
- •6. Gravid women and lactating mother.
- •7. Heavy smoker, Chronic alcoholic, or drug abuse subjects
- •8. Known cases of malignancy, HIV infection, AIDS, etc.
- •9. Subject who participated in any other clinical investigation using an experimental drug in
- •the past 3 months.
- •10. Participants are not willing to sign the ICF and to attend treatment schedule regularly.
研究者
相似试验
招募中
2 期
Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo)IRCT20190210042676N16Akhavi laboratory19
已完成
不适用
Evaluation of the safety and efficacy of the BioWeld1 system in the treatment of acne vulgarisACNE VULGARISL70.0Acne vulgarisDRKS00025008IonMed Ltd.34
尚未招募
1 期
Evaluation of the effectiveness and safety of bianshi moxibustion infrared dry eye therapeutic instrument in the treatment of meibomian gland dysfunctiomeibomian gland dysfunctionITMCTR1900002769Peking University Third Hospital
已完成
不适用
Biomodulina T - IM - covid-19 - older adultPrevention of infections including COVID-19COVID-19SARS-CoV2InfectionsDisease PreventionCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsSARS VirusBetacoronavirusRespiratory Tract InfectionsAgingRPCEC00000319Centro Nacional de Biopreparados (BIOCEN)160
招募中
不适用
Evaluation of the safety and usefulness with biopsy for suspicious renal nodulesKidney cancerJPRN-UMIN000013833Aichi cancer center hospital33
